FDA & CBD: Looking forward

The FDA has announced plans to hold a public meeting next month (April 2019) for the creation of “an appropriately efficient and predictable regulatory framework for regulating cannabidiol (CBD) products,” including food and supplements, Commissioner Scott Gottlieb said during testimony before the House Appropriations Committee.  This is hopeful news for the CBD industry, which is eager to enter the food, drug, and cosmetic industries, but Commissioner Gottlieb has recently announced that he will be resigning.  With Gottlieb on the way out, the status of this meeting will be up in the air until a new Commissioner is appointed.

mdi has been receiving many inquiries on the labeling of food items that contain CBDs. CBDs are not legally allowed to be put in foods at this time. We are waiting on the FDA’s guidelines and regulatory framework before we can provide the proper guidance. It looks like it will be taking a little longer not that the FDA may wait to replace Dr. Gottlieb.

Following the passing of the 2018 Farm Bill, hemp and hemp-derived CBD were removed from the Controlled Substances Act and the FDA was given control over how hemp products, including CBD, could be added to food, drugs, and cosmetics.

We will follow up with an update once an exact date has been set for this meeting.  If you have any questions about CBD and the FDA, feel free to contact us at info@mdiconsultants.com or use our contact form. re: CBD.